BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 15082921)

  • 1. Cyclins and breast cancer.
    Sutherland RL; Musgrove EA
    J Mammary Gland Biol Neoplasia; 2004 Jan; 9(1):95-104. PubMed ID: 15082921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycle machinery: links with genesis and treatment of breast cancer.
    Butt AJ; Caldon CE; McNeil CM; Swarbrick A; Musgrove EA; Sutherland RL
    Adv Exp Med Biol; 2008; 630():189-205. PubMed ID: 18637492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI rats.
    Weroha SJ; Li SA; Tawfik O; Li JJ
    Carcinogenesis; 2006 Mar; 27(3):491-8. PubMed ID: 16311245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models.
    Sutherland RL; Musgrove EA
    Breast Cancer Res; 2002; 4(1):14-7. PubMed ID: 11879554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the CDK inhibitor p27 (Kip1) in mammary development and carcinogenesis: insights from knockout mice.
    Musgrove EA; Davison EA; Ormandy CJ
    J Mammary Gland Biol Neoplasia; 2004 Jan; 9(1):55-66. PubMed ID: 15082918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noxin promotes proliferation of breast cancer cells via P38-ATF2 signaling pathway.
    Zhang X; Zhang Y; Fan C; Wang L; Liu Y; Li A; Jiang G; Zhou H; Cai L; Miao Y
    Tumour Biol; 2017 Jun; 39(6):1010428317705515. PubMed ID: 28618963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T-47D breast cancer cells.
    Hui R; Finney GL; Carroll JS; Lee CS; Musgrove EA; Sutherland RL
    Cancer Res; 2002 Dec; 62(23):6916-23. PubMed ID: 12460907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle.
    Musgrove EA; Lee CS; Buckley MF; Sutherland RL
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8022-6. PubMed ID: 8058751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of relationship between CDK activity and G1 cyclin expression in breast cancer cells.
    Sweeney KJ; Swarbrick A; Sutherland RL; Musgrove EA
    Oncogene; 1998 Jun; 16(22):2865-78. PubMed ID: 9671407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of cyclins D1 and E is frequent in bronchial preneoplasia and precedes squamous cell carcinoma development.
    Lonardo F; Rusch V; Langenfeld J; Dmitrovsky E; Klimstra DS
    Cancer Res; 1999 May; 59(10):2470-6. PubMed ID: 10344760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deregulated expression of p27(Kip1) in human breast cancers.
    Sgambato A; Zhang YJ; Arber N; Hibshoosh H; Doki Y; Ciaparrone M; Santella RM; Cittadini A; Weinstein IB
    Clin Cancer Res; 1997 Oct; 3(10):1879-87. PubMed ID: 9815577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle-dependent expression of cyclin D1 and a 45 kD protein in human A549 lung carcinoma cells.
    Wu F; Bui KC; Buckley S; Warburton D
    Am J Respir Cell Mol Biol; 1994 Apr; 10(4):437-47. PubMed ID: 8136159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis.
    Liao DJ; Natarajan G; Deming SL; Jamerson MH; Johnson M; Chepko G; Dickson RB
    Oncogene; 2000 Mar; 19(10):1307-17. PubMed ID: 10713672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific protection against breast cancers by cyclin D1 ablation.
    Yu Q; Geng Y; Sicinski P
    Nature; 2001 Jun; 411(6841):1017-21. PubMed ID: 11429595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice.
    Wang TC; Cardiff RD; Zukerberg L; Lees E; Arnold A; Schmidt EV
    Nature; 1994 Jun; 369(6482):669-71. PubMed ID: 8208295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene.
    Zukerberg LR; Yang WI; Gadd M; Thor AD; Koerner FC; Schmidt EV; Arnold A
    Mod Pathol; 1995 Jun; 8(5):560-7. PubMed ID: 7675778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of cyclin D1 and E1 expression with bladder cancer presence, invasion, progression, and metastasis.
    Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y
    Hum Pathol; 2006 Dec; 37(12):1568-76. PubMed ID: 16949911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of cyclin D1 in a murine mammary epithelial cell line induces p27kip1, inhibits growth, and enhances apoptosis.
    Han EK; Begemann M; Sgambato A; Soh JW; Doki Y; Xing WQ; Liu W; Weinstein IB
    Cell Growth Differ; 1996 Jun; 7(6):699-710. PubMed ID: 8780883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation.
    Lovec H; Sewing A; Lucibello FC; Müller R; Möröy T
    Oncogene; 1994 Jan; 9(1):323-6. PubMed ID: 8302597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional consequences of cyclin D1 overexpression in human mammary luminal epithelial cells.
    Kamalati T; Davies D; Titley J; Crompton MR
    Clin Exp Metastasis; 1998 Jul; 16(5):415-26. PubMed ID: 10091937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.